A subset of patients with hypophysitis present acutely, with rapidly developing neurological symptoms driven by significant pituitary enlargement. This presentation — marked by mass effects from a swollen gland — requires a structured clinical response that goes beyond watchful waiting.
The defining feature of this presentation is the combination of rapid symptom onset and demonstrable pituitary enlargement causing neurological mass effects. Immunosuppressive therapy is a recognised approach for patients in this acute, symptomatic setting.
DOI: 10.1016/j.beem.2019.101371
Immunosuppressive therapy is utilized for patients with rapid onset of neurological symptoms and mass effects due to pituitary enlargement.
In cases that are refractory to both medical and surgical modalities, stereotactic radiotherapy has been shown to be effective.
View source ↗